Inhibition Of Cell Division In Escherichia Coli By Electrolysis Products From A Platinum Electrode, Nature. 13 févr, vol.205, pp.698-707, 1965. ,
New platinum complexes with anti-tumour activity, Chem Biol Interact. nov, vol.5, issue.6, pp.415-439, 1972. ,
The influence of structure on the activity and toxicity of Pt anti-cancer drugs, Coord Chem Rev, vol.166, pp.181-223, 1997. ,
, , 2017.
,
, , 2017.
,
On the hydrolysis mechanism of the secondgeneration anticancer drug carboplatin, Chem Weinh Bergstr Ger, vol.13, issue.36, pp.10108-10124, 2007. ,
Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells, Biochemistry (Mosc). 4 juill, vol.34, issue.26, pp.8474-80, 1995. ,
Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin, J Clin Oncol Off J Am Soc Clin Oncol. janv, vol.17, issue.1, pp.409-431, 1999. ,
Inhibition of transcription by platinum antitumor compounds, Met Integr Biometal Sci, vol.1, issue.4, pp.280-91, 2009. ,
Recognition of cisplatin adducts by cellular proteins, Mutat Res. 1 juill, vol.478, issue.1-2, pp.1-21, 2001. ,
Platinum resistance: the role of DNA repair pathways, Clin Cancer Res Off J Am Assoc Cancer Res. 1 mars, vol.14, issue.5, pp.1291-1296, 2008. ,
, der Vijgh WJ, vol.21, pp.242-61, 1991.
Pharmacokinetics of carboplatin after i.v. administration, Cancer Treat Rep. déc, vol.71, issue.12, pp.1231-1238, 1987. ,
Carboplatin dosage: prospective evaluation of a simple formula based on renal function, J Clin Oncol Off J Am Soc Clin Oncol, vol.7, issue.11, pp.1748-56, 1989. ,
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II, Cancer Chemother Pharmacol, vol.9, issue.3, pp.140-147, 1982. ,
Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer, J Clin Oncol Off J Am Soc Clin Oncol. avr, vol.10, issue.4, pp.520-528, 1992. ,
Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposure, J Clin Oncol Off J Am Soc Clin Oncol, vol.28, issue.30, pp.4568-74, 2010. ,
Prospective validation of a pharmacologically based dosing scheme for the cisdiamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum, Cancer Res. déc, vol.45, issue.12, pp.6502-6508, 1985. ,
Prediction of carboplatin clearance from standard morphological and biological patient characteristics, J Natl Cancer Inst. 19 avr, vol.87, issue.8, pp.573-80, 1995. ,
Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatin, Clin Pharmacokinet, vol.44, issue.12, pp.1305-1321, 2005. ,
Serum creatinine as an index of renal function: new insights into old concepts, Clin Chem. oct, vol.38, issue.10, pp.1933-53, 1992. ,
Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C, Clin J Am Soc Nephrol CJASN. mars, vol.3, issue.2, pp.348-54, 2008. ,
Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis, Am J Kidney Dis Off J Natl Kidney Found. août, vol.40, issue.2, pp.221-227, 2002. ,
Estimating glomerular filtration rate from serum creatinine and cystatin C, N Engl J Med. 5 juill, vol.367, issue.1, pp.20-29, 2012. ,
A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients, Clin Cancer Res Off J Am Assoc Cancer Res. 15 mai, vol.15, issue.10, pp.3633-3642, 2009. ,
Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids, Br J Cancer. 8 mars, vol.90, issue.5, pp.996-1002, 2004. ,
Cachexia worsens prognosis in patients with resectable pancreatic cancer, J Gastrointest Surg Off J Soc Surg Aliment Tract. juill, vol.12, issue.7, pp.1193-201, 2008. ,
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group, Am J Med. oct, vol.69, issue.4, pp.491-498, 1980. ,
Definition and classification of cancer cachexia: an international consensus, Lancet Oncol. mai, vol.12, issue.5, pp.489-95, 2011. ,
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia, J Am Med Dir Assoc. mai, vol.12, issue.4, pp.249-56, 2011. ,
, European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People, vol.39, pp.412-435, 2010.
Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes, J Surg Oncol. sept, vol.112, issue.4, pp.403-410, 2015. ,
Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib, Med Oncol Northwood Lond Engl. déc, vol.29, issue.4, pp.2793-2802, 2012. ,
Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes, Semin Cell Dev Biol. juin, vol.54, pp.2-10, 2016. ,
Epidemiology of sarcopenia among the elderly in New Mexico, Am J Epidemiol. 15 avr, vol.147, issue.8, pp.755-63, 1998. ,
Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability, J Am Geriatr Soc. mai, vol.50, issue.5, pp.889-96, 2002. ,
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study, Lancet Oncol. juill, vol.9, issue.7, pp.629-664, 2008. ,
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care, Appl Physiol Nutr Metab Physiol Appliquée Nutr Métabolisme, vol.33, issue.5, pp.997-1006, 2008. ,
Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal crosssectional image, J Appl Physiol Bethesda Md, vol.97, issue.6, pp.2333-2341, 1985. ,
, Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review
Toxicity and response criteria of the Eastern Cooperative Oncology Group, Am J Clin Oncol. déc, vol.5, issue.6, pp.649-55, 1982. ,
A formula to estimate the approximate surface area if height and weight be known. 1916. Nutr Burbank Los Angel Cty Calif, vol.5, pp.312-313, 1989. ,
Human body composition: advances in models and methods, Annu Rev Nutr, vol.17, pp.527-58, 1997. ,
Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography, J Appl Physiol Bethesda Md, vol.85, issue.1, pp.115-137, 1985. ,
Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma, Ann Oncol Off J Eur Soc Med Oncol ESMO. août, vol.21, issue.8, pp.1594-1602, 2010. ,
Frequently Asked Questions About GFR Estimates, 2007. ,
Estimating renal function in oncology patients using cystatin C-based equations, Clin Oncol R Coll Radiol G B. juin, vol.21, issue.5, pp.425-431, 2009. ,
DOI : 10.1016/j.clon.2009.01.012
Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children-a meta-analysis, Clin Biochem. mars, vol.40, issue.5-6, pp.383-91, 2007. ,
Prospective evaluation of carboplatin AUC dosing in patients with a BMI>or=27 or cachexia, Cancer Chemother Pharmacol. janv, vol.57, issue.2, pp.241-248, 2006. ,
Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?, Cancer Chemother Pharmacol. juin, vol.64, issue.1, pp.115-137, 2009. ,
Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft-Gault with different weight descriptors, Lung Cancer Amst Neth. janv, vol.79, issue.1, pp.54-62, 2013. ,
Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation, Pharmacotherapy. juill, vol.32, issue.7, pp.604-616, 2012. ,
New Model for Estimating Glomerular Filtration Rate in Patients With Cancer, J Clin Oncol Off J Am Soc Clin Oncol. 20 août, vol.35, issue.24, pp.2798-805, 2017. ,
Development of a new equation to estimate creatinine clearance in cancer patients, Cancer Chemother Pharmacol. juill, vol.76, issue.1, pp.117-141, 2015. ,